764 related articles for article (PubMed ID: 37143162)
41. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
[TBL] [Abstract][Full Text] [Related]
42. Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study.
Incze MA; Chen D; Galyean P; Kimball ER; Stolebarger L; Zickmund S; Gordon AJ
J Addict Med; 2023 Jul-Aug 01; 17(4):401-406. PubMed ID: 37579097
[TBL] [Abstract][Full Text] [Related]
43. Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C.
Andraka-Christou B; Saloner B; Gordon AJ; Totaram R; Randall-Kosich O; Golan M; Stein BD
Am J Drug Alcohol Abuse; 2022 Jul; 48(4):492-503. PubMed ID: 35772010
[No Abstract] [Full Text] [Related]
44. Barriers to Integrated Medication-Assisted Treatment for Rural Patients With Co-occurring Disorders: The Gap in Managing Addiction.
Snell-Rood C; Pollini RA; Willging C
Psychiatr Serv; 2021 Aug; 72(8):935-942. PubMed ID: 33530734
[TBL] [Abstract][Full Text] [Related]
45. Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans.
Petrakis I; Springer SA; Davis C; Ralevski E; Gu L; Lew R; Hermos J; Nuite M; Gordon AJ; Kosten TR; Nunes EV; Rosenheck R; Saxon AJ; Swift R; Goldberg A; Ringer R; Ferguson R
Addict Sci Clin Pract; 2022 Jan; 17(1):6. PubMed ID: 35101115
[TBL] [Abstract][Full Text] [Related]
46. Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons.
Treitler PC; Enich M; Reeves D; Crystal S
Subst Abus; 2022; 43(1):964-971. PubMed ID: 35420973
[No Abstract] [Full Text] [Related]
47. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
Calcaterra SL; Lockhart S; Callister C; Hoover K; Binswanger IA
J Gen Intern Med; 2022 Aug; 37(11):2786-2794. PubMed ID: 34981359
[TBL] [Abstract][Full Text] [Related]
48. Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder.
Fiddian-Green A; Gubrium A; Harrington C; Evans EA
Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35954700
[TBL] [Abstract][Full Text] [Related]
49. Factors associated with clinician treatment recommendations for patients with a new diagnosis of opioid use disorder.
Lin LA; Powell VD; Macleod C; Bohnert ASB; Lagisetty P
J Subst Abuse Treat; 2022 Oct; 141():108827. PubMed ID: 35863212
[TBL] [Abstract][Full Text] [Related]
50. Midwifery Care of Pregnant Individuals Experiencing Opioid use Disorder: Changing Regulations, Complexities, and Call to Action.
Bukowski HB; Combellick JL
J Midwifery Womens Health; 2022 Nov; 67(6):770-776. PubMed ID: 36269042
[TBL] [Abstract][Full Text] [Related]
51. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
Carswell N; Angermaier G; Castaneda C; Delgado F
Hosp Pract (1995); 2022 Oct; 50(4):251-258. PubMed ID: 35837678
[TBL] [Abstract][Full Text] [Related]
52. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
Hughto JMW; Tapper A; Rapisarda SS; Stopka TJ; Palacios WR; Case P; Silcox J; Moyo P; Green TC
Subst Abuse Treat Prev Policy; 2023 May; 18(1):30. PubMed ID: 37217975
[TBL] [Abstract][Full Text] [Related]
53. Opioid use disorder treatment and the role of New Jersey Medicaid policy changes: perspectives of office-based buprenorphine providers.
Mahone A; Enich M; Treitler P; Lloyd J; Crystal S
Am J Drug Alcohol Abuse; 2023 Sep; 49(5):606-617. PubMed ID: 37506336
[No Abstract] [Full Text] [Related]
54. Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?
Grove LR; Rao N; Domino ME
Addiction; 2022 Nov; 117(11):2855-2863. PubMed ID: 35194878
[TBL] [Abstract][Full Text] [Related]
55. Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care.
Chang ET; Oberman RS; Cohen AN; Taylor SL; Gumm E; Mardian AS; Toy S; Revote A; Lewkowitz B; Yano EM
J Gen Intern Med; 2020 Dec; 35(Suppl 3):918-926. PubMed ID: 33145686
[TBL] [Abstract][Full Text] [Related]
56. Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs.
Finlay AK; Wong JJ; Ellerbe LS; Rubinsky A; Gupta S; Bowe TR; Schmidt EM; Timko C; Burden JL; Harris AHS
J Stud Alcohol Drugs; 2018 Nov; 79(6):909-917. PubMed ID: 30573022
[TBL] [Abstract][Full Text] [Related]
57. Dialing for doctors: Secret shopper study of Arizona methadone and buprenorphine providers, 2022.
Meyerson BE; Treiber D; Brady BR; Newgass K; Bondurant K; Bentele KG; Samorano S; Arredondo C; Stavros N
J Subst Use Addict Treat; 2024 May; 160():209306. PubMed ID: 38296033
[TBL] [Abstract][Full Text] [Related]
58. Rationale and design of a multisite randomized clinical trial examining an integrated behavioral treatment for veterans with co-occurring chronic pain and opioid use disorder: The pain and opioids integrated treatment in veterans (POSITIVE) trial.
Vowles KE; Witkiewitz K; Clarke E; Schmidt Z; Borsari B; Edwards KE; Korecki JR; Moniz-Lewis DI; Bondzie JA; Mullins C; Thoreson CI; Delacruz J; Wilkins CH; Nelson S; Delventura J; Henderson R; Katz A; Hua W; Watson E; Baxley C; Canlas BR; Pendleton T; Herbst E; Batki S
Contemp Clin Trials; 2023 Mar; 126():107096. PubMed ID: 36693589
[TBL] [Abstract][Full Text] [Related]
59. Criminal problem-solving and civil dependency court policies regarding medications for opioid use disorder.
Andraka-Christou B; Clark MH; Atkins DN; Del Pozo B
Subst Abus; 2022; 43(1):425-432. PubMed ID: 34236297
[No Abstract] [Full Text] [Related]
60. Health care use and spending for Medicaid patients diagnosed with opioid use disorder receiving primary care in Federally Qualified Health Centers and other primary care settings.
Peterson L; Murugesan M; Nocon R; Hoang H; Bolton J; Laiteerapong N; Pollack H; Marsh J
PLoS One; 2022; 17(10):e0276066. PubMed ID: 36256662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
